Delivery Order SPE2DB24D3013-SPE2DB25FFNWV
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $17,228.37 on August 11, 2025, for the supply of TALTZ 80 MG/ML AutoInjector (2-pack). This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 12, 2025, with performance at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract utilizes no set-aside provisions and represents a routine pharmaceutical procurement through established federal...
- The Defense Logistics Agency awarded a delivery order valued at $21,929.06 to AmerisourceBergen Drug Corp for the supply of TALTZ 80 MG/ML Autoinjector, with an ultimate completion date of July 25, 2025. This competitively awarded, non-set-aside contract employs firm fixed pricing and represents a single delivery order transaction. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $46,054.11 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Taltz 80 mg/mL auto-injector (2-pack) pharmaceutical product. The contract, which is set to be completed by August 1, 2025, will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This competitively awarded delivery order represents a continuation of AmerisourceBergen's ongoing role as a critical pharmaceutical...
- The Defense Logistics Agency awarded a $22,497.98 delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for TALTZ 80 mg/ml autoinjector supply. This is a firm fixed price, non-set-aside contract with a completion date of August 15, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued...
- The Defense Logistics Agency awarded a $10,620.84 delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of TALTZ 80 mg/ml autoinjector medication. This is a firm fixed price, competitively awarded contract with performance scheduled for completion by August 18, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. No set-aside provisions were applied to this award. This delivery order is issued under AmerisourceBergen Drug...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $19,605.32 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of Taltz 80 mg/mL autoinjectors. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 and awarded solely to AmerisourceBergen Drug Corp, which serves as the primary vehicle for the company to deliver pharmaceutical products and medical...
- The Defense Logistics Agency awarded a $14,482.79 delivery order to AmerisourceBergen Drug Corp for the supply of TALTZ 80 mg/mL autoinjector medication. This is a firm fixed-price, non-set-aside contract with a completion date of July 28, 2025, and represents a child order under AmerisourceBergen's larger contract vehicle with DLA. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order operates under...
- The Defense Logistics Agency awarded a $19,447.53 delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of TALTZ 80 MG/ML auto-injector (2-pack) pharmaceutical products. This firm fixed-price delivery order, which concludes on August 15, 2025, represents a competitively awarded contract with no set-aside designation. The products will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania, the company's corporate headquarters and a major...
- The Defense Logistics Agency awarded a $19,479.51 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TALTZ 80 mg/ml auto-injector (2-pack) pharmaceutical supplies on August 8, 2025, with an ultimate completion date of August 11, 2025. The contract is unclassified as a set-aside and represents a child award issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026. The place of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of TALTZ 80 mg/ml autoinjector medication, valued at $72,800.96. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract carries an ultimate completion date of August 1, 2025, and performance will be executed from the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order falls...
- SPE2DB24D3013Indefinite Delivery Contract
- SPE2DB24D3013-SPE2DB25FFNWVDelivery Order
The Defense Logistics Agency awarded a $11,664.67 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TALTZ 80 mg/ml autoinjector on July 31, 2025, with completion due August 1, 2025. This non-set-aside contract represents a small-value pharmaceutical supply delivery executed through AmerisourceBergen's existing federal contract vehicle with DLA. The award leverages the contractor's established relationship with the Defense Logistics Agency Medical Supply Chain, which has consistently utilized AmerisourceBergen as a critical vendor for military and veteran healthcare pharmaceutical procurement. This delivery order is issued under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The parent contract serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a vast range of brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains to support military healthcare programs worldwide. The company's performance of similar competitively awarded delivery orders demonstrates its capability to fulfill federal medical supply requirements efficiently, supporting the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.7k | 7/31/25 |